StockpollyBeta
Get App
Popularity #3,683
ARMP · AMEX · Biotechnology

Armata Pharmaceuticals (ARMP)

Develops bacteriophage cocktails for serious antibiotic-resistant bacterial infections.

$4.20
After hours−0.02 (−0.47%)
At close$4.22(−0.94%)

In millions of USD, except per-share figures

In millionsQ4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue21031020013
Cost of revenue00000000001
Gross profit11031020002
111112121189814912
Research & development88898566668
33333333335
General & administrative33333333335
Other expenses0000000−140−1
Operating income−10−10−12−10−11−8−7−8−14−9−10
−10−15214132−9−19−110−10784
Interest income00000000000
Interest expense12333444567
Other non-operating income913−24−7−16−5615106101−91
Income before tax−20−259−53−7−16−27−124−11574
Net income from continuing operations−20−259−53−7−16−27−124−11574
Net income−20−259−53−7−16−27−124−11574
EPS, basic−$0.55−$0.69−$0.40−$0.15$0.07−$0.18−$0.45−$0.74−$3.42−$3.16$2.02
EPS, diluted−$0.55−$0.69−$0.25−$0.15$0.04−$0.18−$0.45−$0.74−$3.42−$3.16−$0.27
Weighted average shares, basic3636363636363636363737
Weighted average shares, diluted3636583659363636363762
EBITDA−18−2312−26−3−12−22−119−10981
Depreciation & amortization00000000001
EBIT−18−2312−36−3−12−22−119−11081